Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Migraine Disorders

• Intravenous Fluids in Pediatric Migraine
• Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
• Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis
• Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis.
• Chronic Migraine Prophylaxis: Ultrasound-Guided Greater Occipital Nerve Block Versus Medical Treatment
• Mesotherapy in the Treatment of Chronic Migraine
• The Efficacy Of Lidocaine Infusion IN Chronic Unilateral Migraine Headache
• Zolmitriptane as Prophylaxis for Chilhood Migraine
• Intranasal Ketorolac Trial
• Bilateral DLPC tDCS in Drug-resistant Migraine
• A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
• Oral Medications for the Management of Acute Migraine Headache in the Emergency Department
• A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
• Responding With Evidence and Access for Childhood Headaches
• Effect of Sildenafil in Individuals With Migraine Pretreated With Erenumab
• Effect of Levcromakalim in Individuals With Migraine Pretreated With Erenumab
• Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine
• Lacosamide in Migraine Prevention
• Effect of Nicotinic Acid in Prophylaxis of Moderate to Severe Migraine: A Randomized, Double-blind, Placebo-controlled Trial
• A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
• Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis
• Effect of Riocigaut on Migraine Attack Induction and Cerebral Vasodilation in Migraine Patients.
• Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events and Disease Activity in Adult Participants With Migraine
• A Study of Nerve Blocks for Migraines
• COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study
• Habituation of the Nociceptive Blink Reflex in Experimentally Induced Migraine Attack
• A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
• Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Episodic Migraine
• Tai Chi for the Prophylaxis of Episodic Migraine: the Efficacy Examination and Mechanism Exploration
• Naltrexone and Acetaminophen Combination and Its Components in Adult Acute Migraine (AT-06)
• A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine
• Efficacy of GONB in Patients of Migraine
• Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients.
• The Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine Patients
• BOTOX® vs. XEOMIN® for Chronic Migraine
• The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain.
• COMParison of the EffecT of dEvice Closure in Alleviating Migraine With PFO (COMPETE-2)
• Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)
• Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale
• Cabergoline as a Preventive Treatment for Chronic Migraine
• Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications
• Transcutaneous Supraorbital Nerve Stimulator Versus Topiramate in Prevention of Recurrent Migraine
• Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use
• Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies
• Transcutaneous Pulsed Radiofrequency in Migraine
• TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME）
• A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine
• A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
• Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment
• Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine
• Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients
• The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss
• Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects
• Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects
• Long-Term Safety Study of BHV3000 for the Acute Treatment of Migraine in Chinese Subjects
• A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
• Real World Effectiveness of Eptinezumab in Participants With Migraine
• Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine
• Effectiveness of Multimodal Physical Therapy in Migraine
• Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
• Study of Oral Atogepant Tablets When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine
• Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine
• Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine
• Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine
• Sphenopalatine Ganglion Blockade in Migraine
• Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention
• A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
• Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
• A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
• Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
• A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine
• Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
• A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents
• Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan
• A Study Evaluating the Effectiveness of PEA Compared to Placebo for Reducing Pain Severity and Duration of Migraines.
• Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine
• Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention
• Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg vs Placebo as Adjuvant Treatment in Chronic Migraine -
• A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
• Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
• Study of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks
• Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine
• A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine
• Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx)
• Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine
• Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura
• The Effects of Ivabradine on Levcromakalim-induced Migraine
• Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults
• Study to Assess Adverse Events (AEs) When Oral Atogepant Tablet is Given to Adult Chinese Participants Who Completed Study 3101-303-002 to Prevent Chronic Migraine
• A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine
• Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine
• A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
• Eptinezumab in Adults With Migraine and Medication Overuse Headache
• Amitriptyline vs GON and SON Blocks in Migraine
• Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
• Headache Inducing Effect of NN414 in Migraine Patients
• Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
• Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.
• Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room
• Decoding Pain Sensitivity in Migraine With Multimodal Brainstem-based Neurosignature
• Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.
• Fremanezumab, Migraine and Sleep
• A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine
• Registry for Migraine - Structural and Functional MRI Before and After Erenumab Treatment
• Acupuncture for Prophylaxis of Vestibular Migraine
• Randomized Study in Children and Adolescents With Migraine: Acute Treatment
• A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
• Registry for Migraine - Clinical Core
• Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
• Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
• Efficacy of OnabotulinumtoxinA in Migraine
• The Effect of Adenosine on Cranial Hemodynamic, Headache and Migraine Induction Properties.
• Candesartan for Migraine Prevention:
• Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine
• Randomized Trial in Adult Subjects With Acute Migraines
• Medicinal vs. Orthotic Comparison for Migraine Prevention: A Double-Blind Study
• A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab
• Ibuprofen in Migraine Patients
• A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
• A Study of LY3451838 in Participants With Migraine
• Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants
• Comparison of Great Occipital Nerve and Supraorbital Nerve Blockade Methods at Treatment of Acute Migraine Attack in the Emergency Department
• Transnasal Sphenopalatine Ganglia Block for Management of Chronic Migraines in Pediatric Patients
• Efficacy of Erenumab on Functional Impact of Migraine
• A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years of Age
• Efficacy of AJOVY (Fremanezumab-vfrm) on Interictal Migraine Related Burden
• A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
• The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
• A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine
• Tricaprilin Phase 2 Pilot Study in Migraine
• A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Patients That Are Not Helped by Previous Preventive Treatments
• Galcanezumab for Vestibular Migraine
• Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency
• Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine
• A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine
• Treatment of Tinnitus With Migraine Medications
• A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
• A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
• Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of Migraine
• Intravenous Paracetamol, Dexketoprofen and Ibuprofen in the Treatment of Acute Migraine Attack Headache
• Efficacy of Inhaled Cannabis for Acute Migraine Treatment
• A Safety Evaluation Trial of TEV-48125 Self-administered in Migraine Patients
• Onabotulinum Dose Comparison in Chronic Migraine Superior to 100 Units?
• Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL
• A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist
• Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action
• Biomarker and Genetic Predictors of Erenumab Treatment Response
• The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients
• Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine
• Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine
• 1H Magnetic Resonance Spectroscopy in Migraine Patients
• Repeat Dosing of Psilocybin in Migraine Headache
• Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean
• Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine
• Initiating Early Control of Migraine Pain and Associated Symptoms
• A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
• A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine
• Idebenone for the Preventive Treatment of Migraine
• Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab
• Dexamethasone for Migraine - Dose Comparison
• A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine
• GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
• Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea
• Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine
• Open-Label Long-Term Safety Study of AXS-07 for the Acute Treatment of Migraine
• Evaluation of Efficacy and Safety of add-on Alpha-lipoic Acid on Migraine Prophylaxis in Adolescent Population
• Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura
• Therapy for Migraine Prevention in Children 6-11 Years of Age
• A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder
• A Study Investigating the Efficacy of GON Blocks.
• Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients
• Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine
• A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine
• SPG Block for Acute Pediatric Migraine
• A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients
• Cannabis for the Prophylactic Treatment of Migraine
• A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache
• A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine
• A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine
• Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine
• Study of Sustained Benefit of Erenumab in Adult Episodic Migraine Patients
• Saline Injections for Prophylactic Treatment of Chronic Migraine
• Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine
• Ketamine for Refractory Chronic Migraine: a Pilot Study
• Maximizing Outcomes in Treating Acute Migraine
• The Effects of Maxipost (BMS 204352) on Cerebral Hemodynamic and Headache in Healthy Volunteers and Migraine Patients
• Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine
• PACAP38 Induced Headache, Migraine and Flushing in Patients With Migraine
• A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain
• A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
• Acute Treatment Trial in Adult Subjects With Migraines
• Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
• A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine
• Efficacy and Safety of Erenumab in Pediatric Subjects With Episodic Migraine
• Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
• Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine
• A Controlled Trial of Erenumab in Migraine Prevention
• A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine
• 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine
• Imaging the Migraine Brain Pre- and Post-Erenumab
• Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
• Comparison of Therapeutic Effects of Greater Occipital Nerve Block, Topiramate, and Flunarizine on Episodic Migraine
• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine
• Mindfulness Therapy for Chronic Migraine
• A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
• Sphenopalatine Ganglion Blocks RCT
• Sustained onabotulinumtoxinA Therapeutic Benefits in Patients With Chronic Migraine
• CHOCOlate MeLatonin for AdolescenT MigrainE
• 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
• Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department
• A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine
• "Follow the Sutures". A New Procedure for Injection of Botulinum Toxin for Chronic Migraine
• Occipital Blocks for Acute Migraine
• AMG 334 20160172 Pediatric Migraine PK Study.
• Can DFN-15 Terminate Migraine With Allodynia?
• Mind and Body Approaches to Pain Reduction in Youth With Migraine
• PACAP27 Headache Properties in Migraine Without Aura Patients
• ACT Therapy for HF Migraine
• Trial in Adult Subjects With Acute Migraines
• A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
• Topical Bimatoprost in the Treatment of Migraine
• Bioavailability of DHE Administered by I123 POD Device, IV Injection, and Migranal Nasal Spray in Healthy Adults
• Tertiary Care With or Without Manual Therapy for Chronic Migraine
• (Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist
• Psilocybin for the Treatment of Migraine Headache
• Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
• The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users
• An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
• Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
• Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine
• Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine
• A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
• Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
• Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
• Greater Occipital Nerve Block Versus Metoclopramide
• Open Label Safety Study in Acute Treatment of Migraine
• A Study of Lasmiditan in Participants With Migraine
• Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
• Safety and Efficacy in Adult Subjects With Acute Migraines
• Safety and Efficacy Study in Adult Subjects With Acute Migraines
• Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)
• Headache Inducing Effect of Cromakalim in Migraine Patients
• Ketamine v. Ketorolac for Management of Generalized Tension Type Headache
• The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
• BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Participants With Chronic Migraine
• Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea
• Effectiveness and Neural Mechanism of Naoan Dripping Pills for Migraine
• A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks
• Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers
• Melatonin for Adolescent Migraine Prevention Study
• Comparison of Oral Paracetamol and Zolmitriptan Efficacy in the Treatment of Acute Migraine in Emergency Department
• Pharmacologically Triggered Migraine Without Aura and Neuroimaging
• Efficacy and Safety of IONIS-PKKRx for Preventive Treatment of Chronic Migraine
• Status Migrainosus - Differentiating Between Responders and Non-responders
• Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine
• Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain Population
• Understanding the Pathophysiology of Migraine Pain
• The Effects of Caffeine Withdrawal on Migraine
• Efficacy, Tolerability, and Safety of DFN-15
• Efficacy, Tolerability, and Safety Study of DFN-15
• Efficacy of Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency Department
• A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine
• A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine
• Non-pharmacological Management of Chronic Migraine
• Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department
• Migraine Prophylaxis With Clopidogrel Trial
• Endothelin-1 as a Potential Trigger of Migraine Aura
• RCT of IV Dexamethasone to Prevent Relapse in the Treatment of Migraine in a Paediatric ED
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine
• Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine
• An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)
• Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
• Corticosteroids for Acute Migraine in the Emergency Department
• Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine
• Induction of Migraine Aura With Sildenafil
• Oral Dexamethasone for the Treatment of Acute Migraine Recurrence in the Pediatric Emergency Department
• Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females
• A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine
• Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT
• Biomarker Study in Participants With Migraine
• IV Haloperidol for the Treatment of Headache in the ED
• Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
• Cefaliv® Compared to Neosaldina® in the Treatment of Migraine Attacks
• Ketamine for Acute Migraine in the Emergency Department
• GON-block in Chronic Migraine: a Randomized, Double- Blind, Placebo-controlled Study
• Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine
• Auricular Acupuncture vs SOC in Migraine HA
• IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine
• Efficacy and Safety of Danzhen
• Migraine Treatment in ED
• Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis
• Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine
• Timolol Eye Drops in the Treatment of Acute Migraine Headache
• A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention
• Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
• Effect on Migraine Frequency of Combined Anti-oxidant Therapy: The MIGRANT Study.
• Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine
• A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura
• Evaluation of Galcanezumab in the Prevention of Chronic Migraine
• Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
• Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
• Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults
• Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine
• Metformin for the Prevention of Episodic Migraine (MPEM)
• Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks
• Study of Key Electro-acupuncture Technique on Migraine
• Greater Occipital Nerve (GON) Block Effectivity in the Treatment of Chronic Migraine: 6 Months Follow up
• Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine
• DFN-11 Injection in Episodic Migraine With or Without Aura
• Ginger Capsules for the Acute Treatment of Migraine Attacks
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
• A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
• Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI
• To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients
• Ticagrelor Therapy for RefrACTORy Migraine Study
• Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department
• The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache
• Low- Dose Propofol Infusion as an Abortive Treatment for Migraine Headaches in Pediatric Patients
• The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache
• Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention
• Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches
• Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention
• Rizatriptan for Episodic Dizziness in Vestibular Migraine
• Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
• Chronic Migraine Treatment With Botulinum Toxin-A: an Investigation of Functional Magnetic Resonance Imaging Changes.
• Topiramate and Cerebrovascular Response in Migraineurs
• Hydromorphone Versus Prochlorperazine + Diphenhydramine for Acute Migraine
• The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients
• Intranasal Ketorolac Versus Intravenous Ketorolac for Treatment of Migraine Headaches in Children
• Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches
• Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine
• Bringing Relief to Adolescents Naturally Using Melatonin for Migraine
• MLD10 in the Prevention of Migraine in Adults
• The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients
• Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial
• A Study to Evaluate Botulinum Toxin Type A for Injection（HengLi®）for Prophylactic Treatment of Chronic Migraine
• Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds
• DFN-02 Open Label Safety Study in Patients With Acute Migraine
• Botox Injection in Treatment of Chronic Migraine
• Induction of Migraine Aura With Cilostazol
• Chronic Pain Risk Associated With Menstrual Period Pain
• Efficacy, Safety, Tolerability and Pharmacokinetics of BIBN 4096 BS Versus Placebo in the Treatment of a Single Attack of Acute Migraine Headache
• Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults
• Anesthetic Blockades and Migraine
• Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients
• Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache
• Effect of "Sekanjabin e Safarjali" (Quince Oxymel) in the Prevention of Migraine Attacks
• Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine
• A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.
• Trial of Nortriptyline and Topiramate in the Initial Treatment of Vestibular Migraine
• A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
• IV Dexketoprofen vs Placebo in Migranie Attack
• PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load
• Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects
• A Study of LY2951742 in Healthy Japanese and Caucasian Participants
• Prediction of Migraine Prevention Efficacy Based on Individual's Pain Modulation
• Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial
• Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines
• ASIS for Botox in Chronic Migraine
• A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention
• Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine
• Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine
• A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.
• A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
• Assessment of LBR-101 In Chronic Migraine
• A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous Histamine Dihydrochloride for Migraine Prophylaxis
• Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan
• Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo
• Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study
• A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy Adults
• A Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy Adults
• Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine
• Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine
• Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With Migraines
• Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention
• Theramine® in the Prevention of Migraine Headache
• Sphenopalatine Nerve Block for Headache Tx360
• CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load
• Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache
• Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study
• Clinical Effectiveness of Osteopathic Manipulative Treatment in Chronic Migraine
• The Headache Inducing Effects of Cilostazol on Migraine Patients
• TI-001 (Intranasal Oxytocin) for Treatment of High Frequency Episodic Migraine and Chronic Migraine
• A Study of Prophylaxis for Migraine Patients With Topiramate in India
• Use of a Treatment Benefit Questionnaire in Patients With Chronic Migraine Treated With OnabotulinumtoxinA (BOTOX®)
• Diphenhydramine for Acute Migraine
• Efficacy and Safety of Eslicarbazepine Acetate as Preventive Therapy for Subjects With Migraine
• Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment
• A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines
• Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine
• Continuous Treatment Study of Topiramate in Migraine Participants
• Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache
• Safety, Efficacy and Pharmacokinetics of ALD403
• Acetazolamide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow
• Intravenous Dexketoprofen and Paracetamol in the Treatment of Headache Caused by Acute Migraine Attack
• Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.
• Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients
• Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine
• A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency
• A Randomized, Parallel, Double-blind, Placebo-controlled Study of Vitamin D as Prophylactic Treatment for Migraine
• Effect of Acetyl-L-carnitine in Migraine
• Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients
• STOPAIN in the Treatment of a Single Migraine Attack
• An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine
• Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness
• Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
• A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007)
• The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine
• Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive Craniotomy
• Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine
• A Study of LY2951742 in Participants With Migraine
• A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention
• A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006)
• Low-dose Propofol for Pediatric Migraine
• Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department
• The Childhood and Adolescent Migraine Prevention Study
• Prochlorperazine Versus Prochlorperazine & Ketorolac in Treatment of Pediatric Migraine in the Emergency Department
• A Study of the Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Participants With Episodic Migraine (MK-6096-020)
• Cupping and Serkangabin Versus Conventional Migraine Treatment
• Effect of PACAP38/VIP on Migraineurs Measured by Magnetic Resonance
• Multiparametric MRI Study of Endogenous Analgesia and Prediction the Efficacy of Migraine Pharmacological Prevention
• Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine
• Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex
• Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition
• Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine
• Ibuprofen Versus Ibuprofen Plus Caffeine in the Treatment of Migraine.
• Study of Treatment Used for Migraine Headaches (MK-0974-076)
• Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches
• An Open-labeled Trial of Ramipril in Patients With Migraine
• Milnacipran for Migraine Pain
• Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine
• Ibudilast in the Treatment of Patients With Chronic Migraine.
• Prostaglandin E2 in Migraine Suffers Without Aura.
• A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data
• Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy
• Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet
• Drug Use Investigation for IMIGRAN Tablet
• Study With Amitriptylin to Evaluate the Efficacy of Melatonin in Treatment of Migraine
• Treximet ™ Pharmacy Budget Impact Model Database Validation Study
• Special Drug Use Investigation for AMERGE® Tablet (Long-term)
• CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet
• Preventive Treatment of Episodic and Chronic Migraine
• Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine
• Nitrous Oxide for Acute Migraine Pain in the Emergency Room (ED)
• Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Extension Protocols MK-0462-022, MK-0462-025, MK-0462-029)
• Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
• Valproate Versus Ketorolac Versus Metoclopramide
• Lippia Alba for Migraine Prophylaxis and Treatment
• Aspirin Resistance in Women With Migraine
• The Effect of Nasal Carbon Dioxide in the Treatment of Moderate to Severe Migraine
• Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.
• Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine
• A Double-blind, Placebo-controlled Pilot Study to Collect and Evaluate Data on the Use of Intravenous Ibuprofen in the Treatment of an Acute Migraine Attack
• The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine
• Statin/Vitamin D & Migraine Study
• Topical Intra-Oral Ketoprofen for Migraine Prevention
• Zomig - Treatment of Acute Migraine Headache in Adolescents
• A Study in Migraine Prevention
• Mechanism-based Choice of Therapy for Pain: Can Successful Prevention of Migraine be Coupled to a Psychophysical Pain Modulation Profile?
• Efficacy and Safety of Cyclobenzaprine Hydrochloride Extended Release for the Treatment of Chronic Migraine
• An Evaluation Of The Efficacy And Safety Of Donepezil Hydrochloride (E2020) In Migraine Prophylaxis
• Ictal and Interictal Inflammatory Markers in Migraine
• Telcagepant for Prevention of Menstrually Related Migraine in Female Participants With Episodic Migraine (MK-0974-065)
• Comparison of a Drug and Placebo in the Prevention of Migraine Headaches
• Acupuncture in Chronic Migraine: A Randomized Controlled Trial
• Treximet in the Treatment of Chronic Migraine
• Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?
• Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
• A Dose-Finding Study of Topiramate (JNS019) in Participants With Migraine
• Caffeine/Propranolol Intervention for Acute Migraine
• Intravenous Fluid for Pediatric Migraine in the Emergency Department
• Trial of Comprehensive Migraine Intervention
• Calcitonin Gene-related Peptide Levels in Chronic Migraine
• An Efficacy and Tolerability Study of Topiramate in Participants With Migraine
• Sumatriptan and Naratriptan Pregnancy Registry
• Rizatriptan 10 MG RPD in the Treatment of Acute Migraine
• Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches
• Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
• Treximet Early Intervention Adolescent Migraine
• A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)
• A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)
• A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.
• Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents
• Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions
• Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura
• EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model
• Study of NXN 188 for the Treatment of Migraine With Aura
• Greater Occipital Nerve Block for Migraine Prophylaxis
• Drug and Non-Drug Treatment Of Severe Migraine
• Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine
• Treatment of Multiple Attacks of Acute Migraine (0462-025)
• Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)
• MK0462 in Treatment of Migraine With Recurrence (MK0462-022)
• MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)
• A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)
• "Completeness of Response" Following Treatment With Treximet™ for Migraine
• Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
• Efficacy and Safety of BGG492 in the Treatment of Migraine
• Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine
• Candesartan Versus Propranolol for Migraine Prevention
• Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment
• Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura
• An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)
• Pilot Study of BOTOX for Migraine Headaches
• Melatonin for Migraine Prevention
• Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine
• Migraine Study in Adolescent Patients
• Treximet in Acute Migraine Headache: Assessing Cognitive Function
• Staccato Loxapine in Migraine (Out Patient)
• A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine
• ADX10059 Migraine Prevention Study
• Treatment of Insomnia in Migraineurs
• A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
• An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
• Study in Participants With Acute Migraines Headaches
• Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects
• MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)
• A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period
• An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
• A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches
• Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine
• NINDS CRC Chronic Migraine Treatment Trial
• A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)
• Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms.
• A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately
• BI 44370 TA in Acute Migraine Attack
• Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks
• Prevention Study in Adult Patients Suffering From Migraine Headaches
• A Study of a Melatonin Receptor Agonist to Prevent Migraine
• Effect of Dexamethasone on Migraine Headache
• Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness
• The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
• Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period
• Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers
• The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache
• MK3207 for Treatment of Acute Migraines (3207-005)
• Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026)
• Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals
• The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines
• Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)
• Metoclopramide for Migraine: A Dose Finding Study
• Study of Intramuscular Ropivacaine Injections for Treatment of Pediatric Headache
• Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)
• Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
• A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine
• DP-VPA for Migraine Prophylaxis, a Pilot Efficacy Study
• ZAP, US. Zomig for Appropriate for Primary Care
• Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs
• Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy
• Phase 3 Study of MAP0004 in Adult Migraineurs
• Efficacy and Tolerability of Zolmitriptan Nasal Spray
• Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents
• Staccato Prochlorperazine Single Dose PK Study
• Staccato Prochlorperazine in Migraine (in Clinic)
• Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)
• Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department
• TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults
• Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine
• Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
• Trial on Metoclopramide and Ketoprofen in Acute Migraine of Childhood
• A Study of Gastric Delay in Migraine Patients (3207-003)
• Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine
• Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
• Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)
• A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack
• Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2
• Staccato Loxapine in Migraine (in Clinic)
• Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents
• Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine
• Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)
• A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine
• Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
• Comparing Naproxen to Sumatriptan for Emergency Headache Patients
• Efficacy of Pregabalin in Migraine Prevention
• A Research Study Examining The Use Of Duloxetine In The Prevention Of Migraine Headache
• Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)
• Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)
• The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months
• A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
• A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting
• To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches
• To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches
• Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016)
• Staccato Prochlorperazine in Migraine (Out Patient)
• Two Rizatriptan Prescribing Portions for Treatment of Migraine
• A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches
• TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)
• TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine
• A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine
• A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)
• A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
• PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
• Prochlorperazine vs Metoclopramide
• Functional MRI (fMRI) in CGRP Induced Migraine
• Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?
• Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
• Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan
• Treatment of Acute Migraine Headache in Children
• A Research Study Examining Migranal and Skin Sensitivity in Subjects With Migraine
• Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
• Tonabersat in the Prophylaxis of Migraine With Aura
• An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack
• Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks
• Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea
• Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)
• An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine
• Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
• Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis
• A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine
• A Study Comparing the Effectiveness and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for the Treatment of Acute Pain From a Migraine Headache
• An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine
• Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.
• A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache
• Does Topiramate Adjust the Excitability of the Brain in Migraine Sufferers?
• Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine
• Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache
• Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs
• Use Of SB-705498 In The Acute Treatment Of Migraine
• ESCAPE Migraine Trial
• An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With Triptans
• Prospective Survey of Menstrual Migraine & Prevention With Eletriptan
• Zonisamide for Fibromyalgia & Migraine
• Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study
• Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2
• A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches
• Experimental Headache Induced by Vasoactive Intestinal Polypeptide
• A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine
• Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea
• A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)
• Use Of GW274150 In The Prophylactic Treatment Of Migraine
• Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
• Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
• A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children
• A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine
• A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
• A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
• Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
• Oral Dexamethasone for Treatment of Migraine
• The Prolonged Use of Topiramate for Preventing Migraine Headaches
• The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine
• The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain
• Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.
• A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches
• An Open Label Extension of a Study of Topiramate in Chronic Migraine.
• An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.
• Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine Headaches
• A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children
• A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache
• Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
• A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents
• Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers
• Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.
• A Research Study Examining the Use of Olanzapine for the Prevention of Migraine
• A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin Sensitivity
• Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache
• A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches
• Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine
• A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.
• The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
• A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine
• Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches
• A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
• Efficacy and Safety Study of E2007 in Migraine Prophylaxis
• Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
• Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache
• Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines
• Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)
• Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)
• A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
• Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
• Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)
• A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache